Pregled bibliografske jedinice broj: 575867
Antimalarial activity of 9a-N substituted 15-membered azalides with improved in vitro and in vivo activity over azithromycin
Antimalarial activity of 9a-N substituted 15-membered azalides with improved in vitro and in vivo activity over azithromycin // Journal of medicinal chemistry, 55 (2012), 3; 1389-1401 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 575867 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Antimalarial activity of 9a-N substituted 15-membered azalides with improved in vitro and in vivo activity over azithromycin
Autori
Perić, Mihaela ; Fajdetić, Andreja ; Rupčić, Renata ; Alihodžić, Sulejman ; Žiher, Dinko ; Bukvić Krajačić, Mirjana ; Smith, Kirsten S. ; Ivezić-Schönfeld, Zrinka ; Padovan, Jasna ; Landek, Goran ; Jelić, Dubravko ; Hutinec, Antun ; Mesić, Milan ; Ager, Arba ; Ellis, William Y. ; Milhous, Wilbur ; Ohrt, Colin ; Spaventi, Radan
Izvornik
Journal of medicinal chemistry (0022-2623) 55
(2012), 3;
1389-1401
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
antimalarial; azalide; amide; amine; malaria; SAR; efficacy; pharmacokinetic
Sažetak
Novel classes of antimalarial drugs are needed due to emerging drug resistance. Azithromycin, the first macrolide investigated for malaria treatment and prophylaxis, failed as a single agent and thus novel analogues were envisaged as the next generation with improved activity. We synthesized 42 new 9a-N substituted 15-membered azalides with amide and amine functionalities via simple and inexpensive chemical procedures using easily available building blocks. These compounds exhibited marked advances over azithromycin in vitro in terms of potency against Plasmodium falciparum (over 100-fold) and high selectivity for the parasite and were characterized by moderate oral bioavailability in vivo. Two amines and one amide derivative showed improved in vivo potency in comparison to azithromycin when tested in a mouse efficacy model. Results obtained for compound 6u, including improved in vitro potency, good pharmacokinetic parameters, and in vivo efficacy higher than azithromycin and comparable to chloroquine, warrant its further development for malaria treatment and prophylaxis.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Temeljne medicinske znanosti, Farmacija
POVEZANOST RADA
Ustanove:
Fidelta d.o.o.
Profili:
Goran Landek
(autor)
Renata Rupčić
(autor)
Andreja Fajdetić
(autor)
Milan Mesić
(autor)
Antun Hutinec
(autor)
Mihaela Perić
(autor)
Sulejman Alihodžić
(autor)
Zrinka Ivezić
(autor)
Jasna Padovan
(autor)
Mirjana Bukvić
(autor)
Radan Spaventi
(autor)
Dinko Žiher
(autor)
Dubravko Jelić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE